In this edition we mark the sad birthday of 5-year-old Ariel Bibas, the little redhead being held by Hamas with his baby brother and parents. We also want you to know about the courageous stand taken by Ayelet Samerano against the UNWRA secretary-general in Lausanne.
Read about how long can a hostage survive in captivity, about Turkey in NATO, the threats to Israel from Iran and Hezbollah and what the IDF says might happen.
Baring Private Equity Asia (BPEA) and Lumenis announced today that they have entered into a definitive agreement to sell the Lumenis Surgical Business to Boston Scientific (NYSE: BSX) in a transaction valued at $1.07 bln, subject to closing adjustments. The Surgical Business includes laser and fibers solutions for minimally-invasive surgical procedures in Urology and ENT.
The new antibacterial masks, which were tested and approved for use in Israeli hospitals, use an innovative technology that has been proven to kill 12 million resistant bacteria in minutes. (Article in Hebrew)
An innovative butterfly-shaped metal coil was developed by Butterfly Medical to stop BPH symptoms without the need for drugs or surgery.
By certifying with this standard, Zadara has demonstrated it has effective systems in place to support GDPR compliance and similar privacy legislation.
Under the TGA (Australian Therapeutic Goods Administration) approval, PixCell's HemoScreen is cleared for use with adults and infants alike, from as early as 2 months of age.
YOKNEAM, Israel, July 1, 2020 /PRNewswire/ -- Hallura Ltd., an Israeli aesthetic medical company developing the next generation of Hyaluronic Acid (HA) Dermal Fillers, today announced that it has appointed Mr. Paul Navarre to serve as an independent director of Hallura's Board of Directors.
"We are excited to welcome Mr. Paul Navarre as he brings a wealth of knowledge and experience to Hallura's board," said Dr. Shimon Eckhouse, co-founder and Chairman of Hallura. "His exceptional track record made Paul a respected and well-known executive in the industry. Paul shares our vision on how Hallura's technology is disruptive and can transform the industry. Paul's unique insights will help guide the vision and strategic opportunities of Hallura."
Mr. Paul Navarre commented "I am very excited to join the Board of Directors. Hallura is at the forefront of the technology that will allow to access the next generation of aesthetic treatments. The great progresses Hallura did in the last two years make it an exciting time to join the company and I look forward to bringing my experience to the Board."
Paul Navarre has more than 25 years' experience in the pharmaceuticals and consumer goods industries. He was Chief Executive Officer of Ferring Holding Inc (US) between 2017 and 2020, managing activities including commercial operations, clinical development and manufacturing. Previously, as President of Allergan International, he managed a $3 billion specialty care business covering dermatology, ophthalmology, urology and neurosciences. During 10 years at Allergan, Mr. Navarre built a strong track record in the aesthetic medical market, delivering solid business results and developing multiple successful organizations. Before joining Allergan, Mr. Navarre spent 15 years at Procter & Gamble, starting in consumer goods before moving to the company's pharmaceuticals division.
About Hallura Ltd.
Hallura Ltd. brings a disruptive HA technology to the fast growing aesthetic injectables market using proprietary HA crosslinking technology, not involving BDDE. Hallura's HA dermal fillers answer the growing demand for better, safer fillers with natural and soft aesthetic results.
Founded in November 2017 by Dr. Stéphane Meunier, Mrs. Alona Gellerman, Dr. Per Hedén and Dr. Shimon Eckhouse and with its headquarters, R&D, and manufacturing in Yokneam Israel. Hallura is a portfolio company of Alon Medtech Ventures owned by Dr. Shimon Eckhouse.
Contact person: Dr. Stephane Meunier, Chief Executive Officer at Hallura; stephane@hallura.com
SOURCE Hallura Ltd.
On June 18, during Ambassador Hans Docter’s visits Yokneam high tech companies, he met with a group of 30 local startups. The Ambassador is planning a follow up visit to meet with additional companies.
